<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Engineering chimeric PCSK9 for a vaccine against atherosclerosis</dc:title><dc:creator>Malenšek,	Špela	(Avtor)
	</dc:creator><dc:creator>Lainšček,	Duško	(Avtor)
	</dc:creator><dc:creator>Esih,	Hana	(Avtor)
	</dc:creator><dc:creator>Orehek,	Sara	(Avtor)
	</dc:creator><dc:creator>Fink,	Tina	(Avtor)
	</dc:creator><dc:creator>Golob Urbanc,	Anja	(Avtor)
	</dc:creator><dc:creator>Blinc,	Aleš	(Avtor)
	</dc:creator><dc:creator>Jerala,	Roman	(Avtor)
	</dc:creator><dc:date>2025</dc:date><dc:date>2025-09-26 10:37:17</dc:date><dc:type>Neznano</dc:type><dc:identifier>23713</dc:identifier><dc:identifier>UDK: 577</dc:identifier><dc:identifier>ISSN pri članku: 2329-0501</dc:identifier><dc:identifier>COBISS_ID: 250323715</dc:identifier><dc:language>sl</dc:language><dc:rights>© 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy. 
</dc:rights></metadata>
